Aspects of the History and Nomenclature of Amyloid and Amyloidosis

  • Per WestermarkEmail author
Part of the Current Clinical Pathology book series (CCPATH)


This chapter deals with some aspects of the history of amyloid and its evolving nomenclature. The history is interesting and contains some of the characteristics of human behavior, including envy and rigidity. Those with a particular interest are referred to a number of earlier publications [1–5]. In addition, some very interesting aspects of the modern history can be found in the proceedings from the international symposia on amyloidosis, particularly the first ones [6, 7].


Systemic amyloidosis History Nomenclature Congo red Fibrils 


  1. 1.
    Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine. 1975;54:271–99.CrossRefPubMedGoogle Scholar
  2. 2.
    Glenner GG. Amyloid deposits and amyloidosis. The β-fibrilloses. N Engl J Med. 1980;302:1283–92. 1333–43.CrossRefPubMedGoogle Scholar
  3. 3.
    Cohen AS. General introduction and a brief history of amyloidosis. In: Marrink J, van Rijswijk MH, editors. Amyloidosis. Dordrecht: Martinus Nijhoff Publishers; 1986. p. 3–19.CrossRefGoogle Scholar
  4. 4.
    Sipe JD, Cohen AS. Review: history of the amyloid fibril. J Struct Biol. 2000;130:88–98.CrossRefPubMedGoogle Scholar
  5. 5.
    Westermark P. Amyloidosis and amyloid proteins: brief history and definitions. In: Sipe JD, editor. Amyloid proteins. The beta sheet conformation and disease. Weinheim: Wiley-VCH; 2005. p. 3–27.Google Scholar
  6. 6.
    Mandema E et al., editors. Amyloidosis. Amsterdam: Excerpta Medica; 1968.Google Scholar
  7. 7.
    Wegelius O, Pasternack A, editors. Amyloidosis. London: Academic; 1976.Google Scholar
  8. 8.
    Virchow R. Ueber eine im Gehirn und Ruckenmark des Menschen aufgefunde Substanz mit der chemishen Reaction der Cellulose. Virchows Arch Path Anat. 1854;6:135–8.CrossRefGoogle Scholar
  9. 9.
    Friedreich N, Kekulé A. Zur Amyloidfrage. Virchows Arch Pathol Anat. 1859;16:50–65.CrossRefGoogle Scholar
  10. 10.
    Wild C. Beitrag zur Kenntnis der amyloiden und der hyalinen Degeneration des Bindegewebes. Beitr Path Anat Physiol. 1886;1:175–200.Google Scholar
  11. 11.
    Soyka J. Ueber die amyloide Degeneration. Prag Med Wschr. 1876;1:165–71.Google Scholar
  12. 12.
    Sipe JD et al. Updated nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidoses. Amyloid. 2014;21:221–4.CrossRefPubMedGoogle Scholar
  13. 13.
    Lubarsch O. Zur Kenntnis ungewöhnlicher Amyloidablagerungen. Virchows Arch Path Anat. 1929;271:867–89.CrossRefGoogle Scholar
  14. 14.
    Herrera GA. The kidney in plasma cell dyscrasias: a current view and a look at the future. Contrib Nephrol. 2007;153:1–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Vossius A. Ueber amyloide Degeneration der Conjunctiva. Beitr Path Anat Allg Path. 1889;4:335–60.Google Scholar
  16. 16.
    Ostertag B. Demonstration einer eigenartigen familiären “Paramyloidose”. Zentralbl Pathol. 1933;56:253–4.Google Scholar
  17. 17.
    Andrade C. A peculiar form of peripheral neuropathy: familial atypical generalized amylodosis with special involvement of the peripheral nerves. Brain. 1952;75:408–27.CrossRefPubMedGoogle Scholar
  18. 18.
    Costa PP, Figueira AS, Bravo FR. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA. 1978;75:4499–503.PubMedCentralCrossRefPubMedGoogle Scholar
  19. 19.
    Tawara S et al. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun. 1983;116:880–8.CrossRefPubMedGoogle Scholar
  20. 20.
    Saraiva MJ. Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies. Expert Rev Mol Med. 2002;4(12):1–11.CrossRefPubMedGoogle Scholar
  21. 21.
    Connors LH et al. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid. 2003;10:160–84.CrossRefPubMedGoogle Scholar
  22. 22.
    Rowczenio DM et al. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat. 2014;35(9):E2403–12.CrossRefPubMedGoogle Scholar
  23. 23.
    Benson MD et al. Leucocyte chemotactic factor 2: a novel renal amyloid protein. Kidney Int. 2008;74(2):218–22.CrossRefPubMedGoogle Scholar
  24. 24.
    Cohen AS, Calkins E. Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature. 1959;183:1202–3.CrossRefPubMedGoogle Scholar
  25. 25.
    Eanes ED, Glenner GG. X-ray diffraction studies on amyloid filaments. J Histochem Cytochem. 1968;16:673–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Divry P, Florkin M. Sur les propriétées optiques de l’amyloide. Comp Rend Soc Biol (Paris). 1927;97:1808–10.Google Scholar
  27. 27.
    Romhányi G. Uber die submikroskopische Struktur des Amyloid. Schweiz Z Path (Path Microbiol). 1949;12:253–62.Google Scholar
  28. 28.
    Benditt EP, Eriksen N. Chemical classes of amyloid substance. Am J Pathol. 1971;65:231–52.PubMedCentralPubMedGoogle Scholar
  29. 29.
    Benditt EP et al. The major proteins of human and monkey amyloid substance: common properties including unusual N-terminal amino acid sequences. FEBS Lett. 1971;19:169–73.CrossRefPubMedGoogle Scholar
  30. 30.
    Glenner GG et al. Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analysis. Science. 1971;172:1150–1.CrossRefPubMedGoogle Scholar
  31. 31.
    Sletten K, Westermark P, Natvig JB. Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med. 1976;143:993–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Bennhold H. Eine specifische Amyloidfärbung mit Kongorot. Münch Med Wochenschr. 1922;69:1537–8.Google Scholar
  33. 33.
    Steensma DP. “Congo” red. Out of Africa? Arch Pathol Lab Med. 2001;125(2):250–2.PubMedGoogle Scholar
  34. 34.
    Bennhold H. Über die Asscheidung intravenös einverbleibten Kongorotes bei den verschiedensten Erkrankungen insbesondere bei Amyloidosis. Deutsch Arch Klin Med. 1923;142:32–46.Google Scholar
  35. 35.
    Morgan WKC, Mules JE. The intravenous Congo red test: a description of some unrecognized fallacies with suggested improvements. Am J Med Sci. 1960;239(1):61–70.CrossRefGoogle Scholar
  36. 36.
    Ouchi E et al. Clinical significance of Congo red test. Tohoku J Exp Med. 1976;118(suppl):191–8.CrossRefPubMedGoogle Scholar
  37. 37.
    Patra S, Jhala CI, Patra BS. Intravenous Congo red test in pulmonary tuberculosis for detection of amyloidosis, its value and limitations. J Assoc Physicians India. 1976;24(9):553–7.PubMedGoogle Scholar
  38. 38.
    Afkhami A, Moosavi A. Adsorptive removal of Congo red, a carcinogenic textile dye, from aqueous solutions by maghemite nanoparticles. J Hazard Mat. 2010;174:398–403.CrossRefGoogle Scholar
  39. 39.
    Griesbach H. Weitere Untersuchungen über Azofarbstoffe behufs Tinction menchlischer und thierischer Gewebe. Zeitschr Wissenschaft Mikroskop Microskop Tech. 1886;3:358–85.Google Scholar
  40. 40.
    Symmers WSC. Primary amyloidosis: a review. J Clin Pathol. 1956;9:187–211.PubMedCentralCrossRefPubMedGoogle Scholar
  41. 41.
    Gafni J, Sohar E. Rectal biopsy for the diagnosis of amyloidosis. Am J Med Sci. 1960;240:332–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Editorial. Clinical diagnosis of amyloidosis. J Am Med Assoc. 1963;183(13):1104.Google Scholar
  43. 43.
    Westermark P, Stenkvist B. A new method for the diagnosis of systemic amyloidosis. Arch Intern Med. 1973;132:522–3.CrossRefPubMedGoogle Scholar
  44. 44.
    Hawkins PN et al. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression. Quart J Med. 1993;86:365–74.PubMedGoogle Scholar
  45. 45.
    Gellerstedt N. Die elektive, insuläre (Para-)Amyloidose der Bauchspeicheldrüse. Zugleich en Beitrag zur Kenntnis der “senilen Amyloidose”. Beitr Path Anat. 1938;101:1–13.Google Scholar
  46. 46.
    Benson MD et al. Hereditary systemic immunoglobulin light-chain (AL) amyloidosis. XIVth International Symposium Amyloidosis, April 27–May 1, 2014, Indianapolis, IN.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Department of Immunology, Genetics and Pathology, Rudbeck LaboratoryUppsala UniversityUppsalaSweden

Personalised recommendations